Fmoc-L-Trp-OSu

Fmoc-L-Trp-OSu is an Fmoc-protected L-tryptophan N-[(9H-fluoren-9-yl)methoxycarbonyl] derivative bearing an activated N-hydroxysuccinimide ester (OSu) at the carboxyl position. The indole side chain of L-tryptophan provides aromatic π-systems for noncovalent interactions and can participate in electrophilic substitution or controlled oxidation chemistry, while the stereogenic center at the α-carbon fixes the L-configuration required for stereochemically consistent peptide coupling. The OSu ester converts the amino acid carboxyl group into a highly reactive acylating handle that can be captured by amines to form amide bonds under mild, peptide-compatible conditions, and the Fmoc carbamate enables orthogonal base-mediated deprotection in solid-phase or solution-phase workflows. The combination of an Fmoc-protected amino terminus with a leaving-group-activated carboxyl group makes Fmoc-L-Trp-OSu a chiral acylating intermediate for building peptide sequences and for preparing downstream tryptophan-containing conjugates.

1. Peptide Synthesis

Fmoc-L-Trp-OSu is applied in peptide building workflows where an Fmoc-protected amino acid must be coupled with defined stereochemistry to a growing peptide chain. The Fmoc group on the nitrogen supports orthogonal protection strategies, while the OSu-activated carboxyl group readily forms amide linkages with peptide-resin-bound or solution-phase amines. The indole side chain remains protected from direct acylation yet can be carried through coupling steps, enabling preparation of tryptophan-containing peptides for structure-activity relationship studies and fragment assembly. The resulting amide formation pathway supports consistent incorporation of L-tryptophan residues into peptide analogs and can be integrated into automated peptide synthesis logistics.

2. Bioconjugation Chemistry

Fmoc-L-Trp-OSu is suitable for bioconjugation and protein-labeling chemistry that requires controlled acylation of primary amines. The OSu ester provides an activated carboxyl functionality that can react with lysine side chains, N-terminal amines, or engineered amine tags to generate stable amide bonds, while the Fmoc group can serve as a removable handle for subsequent peptide-like transformations. The indole moiety of the tryptophan residue can contribute to spectroscopic readouts and hydrophobic/aromatic recognition in conjugates, supporting analytical tracking and molecular interaction mapping. Downstream conjugate formation can be used to generate tryptophan-bearing probes, amide-linked linkers, and acylated biomolecule derivatives for chemical biology investigations.

3. Amino Acid Derivatization

Fmoc-L-Trp-OSu is used as a chiral amino acid derivatization intermediate for installing tryptophan-derived acyl groups onto amine-containing substrates. The activated OSu ester enables rapid conversion of the carboxyl functionality into an amide, allowing preparation of N-acylated derivatives such as amine-functionalized tryptophan conjugates, spacer-containing intermediates, and protected or semi-protected building blocks. The Fmoc-protected nitrogen provides a stable, orthogonally removable protecting-group strategy that can be retained during derivatization and later removed to regenerate an Fmoc-free amino acid derivative for coupling. The stereochemical integrity of the L-configuration supports downstream synthesis routes that require stereodefined tryptophan incorporation into larger molecules.

4. Peptidomimetics Construction

Fmoc-L-Trp-OSu is applied in peptidomimetic and amino-acid-based scaffold construction where tryptophan residues are introduced as defined stereochemical elements. The OSu ester supports amide bond formation to attach tryptophan-derived carbonyl units to amine-bearing scaffolds, while the indole side chain can be leveraged to tune aromatic stacking, hydrophobic character, and conformational preferences in analogs. The Fmoc protection strategy allows the compound to function as an intermediate compatible with peptide-like assembly logic, including orthogonal deprotection steps that align with iterative synthesis of constrained or modified backbones. The resulting tryptophan-containing amide linkages can be carried into SAR studies and molecular design campaigns that evaluate how side-chain presentation affects binding motifs.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-Trp-OSu is utilized in pharmaceutical intermediate preparation where stereodefined tryptophan acyl units are required for synthesis of peptide-like intermediates and amide-linked fragments. The OSu-activated carboxyl group enables conversion into amide-bearing intermediates with amine-functionalized cores, supporting modular fragment assembly in process chemistry and fine chemical synthesis. The Fmoc protecting group provides a controllable protection state for the amino functionality, supporting downstream deprotection and re-coupling strategies that fit manufacturing-oriented route design. The indole side chain introduces an aromatic handle that can be maintained through intermediate stages and subsequently used in derivatization or analytical characterization of tryptophan-containing intermediates.

6. Analytical Research Standards

Fmoc-L-Trp-OSu is suitable for analytical research and reference-material preparation where defined tryptophan-containing amide structures are needed for method development. The combination of an Fmoc-protected amino group and an OSu-activated carboxyl group supports reproducible formation of amide standards with amine-containing analytes, generating consistent chemical structures for LC-MS, HPLC, and MS/MS method validation. The indole chromophore can provide characteristic ionization behavior and fragmentation patterns, supporting traceable identification of tryptophan-derived motifs in complex matrices. The stereochemically defined L-configuration helps ensure that analytical standards reflect the stereochemical identity relevant to amino acid chemistry and peptide science workflows.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

4. Myotropic activity of allatostatins in tenebrionid beetles

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes